as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹30.26
Change
+0.54 (1.82%)
Open
₹29.58
Prev. Close
₹29.72
Day High
₹30.42
Day Low
₹29.58
Volume Analysis
Traded
6,708
Delivered
5,896
Delivery %
87.9%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹31.44 | ₹30.93 | ₹30.6 | ₹30.09 | ₹29.76 | ₹29.25 | ₹28.92 |
| Fibonacci | ₹30.93 | ₹30.61 | ₹30.41 | ₹30.09 | ₹29.77 | ₹29.57 | ₹29.25 |
| Camarilla | ₹30.49 | ₹30.41 | ₹30.34 | ₹30.09 | ₹30.18 | ₹30.11 | ₹30.03 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-8.25%
1 Week
-4.51%
1 Month
+2.51%
3 Months
+0.0%
6 Months
-4.75%
1 Year
-22.41%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
Biofil Chem & Pharma Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 50/100. The strongest factor is Corporate Governance (85/100), while Institutional Ownership (30/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
50/100 — AverageData confidence: 61/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Board approved Q2 FY26 results; manufacturing facility upgradation expected in 3-6 months.
Certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018 for the quarter ended 30th September, 2026
Trading window closed from 1 October 2026 ahead of Q2 FY26 unaudited results.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 53.11% | 53.08% | 53.11% | 53.1% | 53.11% | 53.11% | 53.1% | 53.12% | 53.13% | 53.12% | 53.13% | 53.13% |
| Promoters | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.82% | 46.79% | 46.79% | 46.79% | 46.79% | 46.79% |
| FII | 0.0% | 0.03% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Biofil Chem & Pharma Ltd (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 451,075 | 36.7 | 5.05 | 16.0% |
| Divi S Laboratories Ltd | 294,139 | 86.1 | 16.34 | 16.5% |
| Torrent Pharmaceuticals L | 177,632 | 81.8 | 9.67 | 27.4% |
| Apollo Hospitals Enter. L | 125,893 | 55.6 | 11.86 | 21.5% |
| Laurus Labs Limited | 125,380 | 93.6 | 20.73 | 18.3% |
| Zydus Lifesciences Ltd | 118,693 | 26.2 | 4.27 | 21.2% |
Which Mutual Funds Hold Biofil Chem & Pharma Ltd?
Frequently Asked Questions about Biofil Chem & Pharma Ltd
Biofil Chem & Pharma Ltd (BIOFILCHEM) closed at ₹30.26 on NSE on 19 November 2026, up 0.54 (1.82%) from the previous close.
Biofil Chem & Pharma Ltd trades on the NSE (National Stock Exchange of India) under the symbol BIOFILCHEM.
Biofil Chem & Pharma Ltd has a TopFund Quality Score of 50/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Biofil Chem & Pharma Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.